Citius Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTOR and other ETFs, options, and stocks.About CTOR
Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.
CTOR Key Statistics
Stock Snapshot
With a market cap of 104.6M, Citius Oncology(CTOR) trades at $1.12. The stock has a price-to-earnings ratio of -2.41.
As of 2026-09-20, Citius Oncology(CTOR) stock has fluctuated between $1.01 and $1.16. The current price stands at $1.12, placing the stock +10.9% above today's low and -3.0% off the high.
Citius Oncology(CTOR) shares are trading with a volume of 337.47K, against a daily average of 141.87K.
In the last year, Citius Oncology(CTOR) shares hit a 52-week high of $2.25 and a 52-week low of $0.49.
In the last year, Citius Oncology(CTOR) shares hit a 52-week high of $2.25 and a 52-week low of $0.49.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.